Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 959
Braz. J. Pharm. Sci. (Online) ; 59: e21345, 2023. tab
Article in English | LILACS | ID: biblio-1439504


Abstract This work analyzed the pharmacotherapeutic problems identified by the clinical pharmacist in an intensive care unit (ICU) and the acceptance of pharmaceutical interventions in solving these problems. This is a descriptive cross-sectional retrospective study, carried out in the adult ICU of a public hospital. All patients hospitalized during the study period had their pharmacotherapy monitored and those whose stay at the ICU lasted less than 24 hours were excluded. The pharmacotherapeutic problems were classified according to type, cause, acceptability/implementation, mode of intervention, outcome and related pharmacotherapeutic group. 302 patients were followed up and 350 pharmacotherapeutic problems were identified. Most of them were classified as unnecessary drug-treatment (n=186; 53.1%). The most frequent causes were excessive drug administration (n=181; 97.3%), and antimicrobials was the main group of drugs associated to that type of problem. 350 pharmaceutical interventions were performed, highlighting "prescriber informed only" (n=178; 50.9%), with an average acceptability of 90.7%, with those carried out on site being more effective (93.4%). The number of pharmacotherapeutic problems that were totally solved was 282 (80.6%). Clinical pharmacy activities in the ICU identified, prevented and corrected pharmacotherapeutic problems, contributing to the optimization of pharmacotherapy in aspects related to the need, efficacy and safety of treatments.

Humans , Male , Female , Patients/classification , Pharmaceutical Services/ethics , Intensive Care Units/organization & administration , Organization and Administration/standards , Pharmacists/classification , Pharmaceutical Preparations/administration & dosage , Patient Safety/standards , Evidence-Based Pharmacy Practice/trends
Braz. J. Pharm. Sci. (Online) ; 59: e21931, 2023. tab, graf
Article in English | LILACS | ID: biblio-1439527


Abstract Syphilis is a disease with compulsory and mandatory notification to the Notifiable Diseases Information System (SINAN), with benzathine benzylpenicillin being the treatment of choice. The aim of the study was to compare the consumption of benzylpenicillin benzathine, from the dispensation, between the health regions of a capital in the southern region of the country, according to the georeferencing of notified cases of syphilis. This is a descriptive, cross-sectional, retrospective study of the use of benzylpenicillin benzathine and of reported cases of syphilis. Data on syphilis cases were obtained from notifications made in SINAN, and drug consumption data were obtained from the Municipal Health Department computerized system for Drug Dispensing from January 1st, 2019 to December 31st, 2019. Notifications and drug consumption were georeferenced according to 8 health regions. From the compilation of data, the rates of cases and consumption in relation to the population of each region were calculated. A total of 3188 notifications and a total of 35191 vials of benzathine benzylpenicillin were analyzed. The ratio of vials by SINAN notifications showed that each patient took 11 vials of the drug, which is a higher value if we consider that the complete treatment is 2 to 6 vials per case.

Penicillin G/analysis , Pharmaceutical Services/supply & distribution , Syphilis/prevention & control , Economics , Disease/classification , Health Surveillance System , Geographic Mapping
Braz. J. Pharm. Sci. (Online) ; 59: e21244, 2023. tab
Article in English | LILACS | ID: biblio-1429955


Abstract We evaluated the implementation of the outpatient pharmaceutical office in a teaching hospital regarding the access to medicines available in the Unified Health System - SUS. This is a descriptive-analytical study, based on secondary data analysis of 735 appointments performed by the pharmacist from 2015 to 2017. Of the drugs prescribed to patients attended at the outpatient pharmacist office, 86.39% were listed in the National List of Essential Medicines - RENAME, of which 95.43% belonged to the Specialized Component of Pharmaceutical Assistance. Evaluating the patient's diagnosis against the inclusion criteria of the Clinical Protocols and Therapeutic Guidelines (PCDT), that the most frequent pharmaceutical interventions were: adequacy of the medication request documents (56.4%) and examination requests for pharmacotherapeutic follow up (28.5%). When the prescribed drugs were not included in RENAME/PCDT, the intervention was accepted in 90.3% of the proposals for exchange with available drug in SUS. Still, it was possible to refer the patient to primary care for renewal of continuity of treatment in 95.1% of cases. In conclusion, the role of the clinical pharmacist contributes to the resolution of untreated health problems by promoting access to medicines within the scope of SUS and their rational use in accordance with the PCDT.

Pharmaceutical Services/ethics , Unified Health System , Access to Essential Medicines and Health Technologies , Health Services Accessibility/statistics & numerical data , Outpatient Clinics, Hospital/organization & administration , Outpatients/classification
Braz. J. Pharm. Sci. (Online) ; 59: e21425, 2023. tab, graf
Article in English | LILACS | ID: biblio-1429965


Abstract The University Pharmacy Program (FU), from the Federal University of Rio de Janeiro (UFRJ), was created based on the need to offer a curricular internship to students of the Undergraduate Course at the Faculty of Pharmacy. Currently, it is responsible for the care of about 200 patients/day, offering vacancies for curricular internships for students in the Pharmacy course, it has become a reference in the manipulation of many drugs neglected by the pharmaceutical industry and provides access to medicines for low-income users playing an important social function. Research is one of the pillars of FU-UFRJ and several master and doctoral students use the FU research laboratory in the development of dissertations and theses. As of 2002, the Pharmaceutical Care extension projects started to guarantee a rational and safe pharmacotherapy for the medicine users. From its beginning in 1982 until the current quarantine due to the COVID-19 pandemic, FU-UFRJ has been adapting to the new reality and continued to provide patient care services, maintaining its teaching, research, and extension activities. The FU plays a relevant social role in guaranteeing the low-income population access to special and neglected medicines, and to pharmaceutical and education services in health promotion.

Pharmacy/classification , Education, Pharmacy , COVID-19/classification , Patients/classification , Pharmaceutical Services/history , Teaching/ethics , Pharmaceutical Preparations/supply & distribution , Patient Care/ethics
Article in English, Portuguese | LILACS, BDENF | ID: biblio-1434350


Objetivo: identificar, a partir de publicações científicas, indicadores de qualidade para a otimização da gestão em farmácia hospitalar. Método: revisão integrativa com levantamento bibliográfico nas bases de dados Scopus, Web of Science e Medline, entre 2019 e 2023, utilizando os descritores Patient Safety, Quality Indicators e Pharmacy Service. Foram incluídos documentos em português, inglês e espanhol, com os resumos disponíveis nas bases de dados selecionadas e disponíveis na íntegra sem custos. Para análise dos documentos, aplicou-se a ferramenta CASP adaptada. Resultados: foram identificados 15 documentos na Web of Science, 24 na Scopus e dois na Medline com a temática abordada no tópico. Conclusão: as ferramentas de gestão da qualidade mais frequentemente reportadas foram as relacionadas com a definição da causa raiz. Os indicadores de qualidade utilizados para monitorar os resultados foram, principalmente, satisfação da equipe de trabalho, tempo gasto na execução das atividades e redução de erros e custos.

Objective: to identify, from scientific publications, quality indicators for optimizing management in hospital pharmacy. Method:integrative review with bibliographic survey in the databases Scopus, Web of Science and Medline, between 2019 and 2023, using the descriptors Patient Safety, Quality Indicators and Pharmacy Service. Documents were included in Portuguese, English and Spanish, with abstracts available in the selected databases and available in full at no cost. The adapted CASP tool was used to analyze the documents. Results: 15 documents were identified in Web of Science, 24 in Scopus and two in Medline with the theme addressed in the topic. Conclusion: the most frequently reported quality management tools were those related to root cause definition. The quality indicators used to monitor the results were mainly satisfaction of the work team, time spent performing the activities, and reduction of errors and costs.

Objetivo: identificar, a partir de publicaciones científicas, indicadores de calidad para optimizar la gestión en farmacia hospitalaria.Método: revisión integrativa con levantamiento bibliográfico en las bases de datos Scopus, We of Science y Medline, entre 2019 y 2023, utilizando los descriptores Seguridad del Paciente, Indicadores de Calidad y Servicio de Farmacia. Se incluyeron documentos en portugués, inglés y español, con resúmenes disponibles en las bases de datos seleccionadas y disponibles en su totalidad sin costo. Para el análisis de los documentos se utilizó la herramienta CASP adaptada. Resultados: foram identificados 15 documentos na Web of Science, 24 na Scopus e dois na Medline com a temática abordada no tópico. Conclusión: las herramientas de gestión de la calidad más utilizadas fueron las relacionadas con la definición de la causa raíz. Los indicadores de calidad utilizados para monitorizar los resultados fueron principalmente la satisfacción del equipo de trabajo, el tiempo empleado en la realización de las actividades y la reducción de errores y costes.

Humans , Male , Female , Pharmacy Service, Hospital/organization & administration , Total Quality Management , Quality Indicators, Health Care , Pharmaceutical Services , Patient Safety , Job Satisfaction
Rev. direito sanit ; 22(2): e0001, 20221230.
Article in Portuguese | LILACS | ID: biblio-1419236


O artigo discutiu os requisitos ínsitos do laudo médico e receituário decorrentes do julgamento do Recurso Especial n. 1.657.156/RJ, no qual o Superior Tribunal de Justiça fixou as bases de observância obrigatória por todos os juízes brasileiros para determinação de fornecimento de fármacos não constantes das listas oficiais do Sistema Único de Saúde. Foi feita pesquisa bibliográfica e documental, com abordagem qualitativa e exploratória, a partir do acórdão disponibilizado pelo portal do Superior Tribunal de Justiça; seguiu-se, então, para consultas às demais fontes bibliográficas, dentre as quais Google Scholar, Biblioteca Virtual em Saúde, Scientific Electronic Library Online e Biblioteca Digital Brasileira de Teses e Dissertações do Instituto Brasileiro de Informação em Ciência e Tecnologia. Por fim, passou-se à análise dos achados e, com embasamento teórico e empírico, buscou-se compreender e justificar as exigências relativas a laudo médico utilizado em ações judiciais, em uma tentativa de contribuir para a gestão da política sanitária e dos próprios processos judiciais, bem como para a popularização do precedente. Concluiu-se que o precedente do Superior Tribunal de Justiça levara à exigência de laudos médicos com mais informações, demandando nova atuação dos médicos, e à expectativa de priorização dos protocolos clínicos, das diretrizes terapêuticas e dos medicamentos constantes das listas oficiais do Sistema Único de Saúde.

The article discussed the requirements of medical reports and prescriptions resulting from the judgement of Special Appeal nº 1.657.156/RJ, in which the High Court of Justice established the compulsory adoption measures that all Brazilian judges must follow to decide on the supply of drugs that are not listed in the official Brazilian Unified Health System. This is a bibliographic and documentary research, with a qualitative and exploratory approach, based on the electronic document availability of the judgement trough the High Court of Justice portal. This research followed a critical approach, and entailed searches in various bibliographic sources, including: Google Scholar, Virtual Health Library, Scientific Electronic Library Online and the Brazilian Digital Library of Dissertations and Theses of the Brazilian Institute of Information in Science and Technology. Finally, we proceeded to the analysis of the findings, and, with a theoretical and empirical basis, we sought to understand and justify the requirements related to the medical report used in the lawsuits. This had the purpose of contributing to both the management of the health policy and the legal processes themselves, and the popularization of the requirements. It is concluded that these requirements will conduct to having medical reports with more information, doctors aware of important actions, and prioritization of clinical protocols, therapeutic guidelines and medications included in the official lists of Brazilian Unified Health System.

Pharmaceutical Services , Jurisprudence
J. bras. econ. saúde (Impr.) ; 14(3): 253-258, dezembro 2022.
Article in Portuguese | LILACS, ECOS | ID: biblio-1414904


Objetivo: Esclarecer o impacto farmacoterapêutico e farmacoeconômico das intervenções farmacêuticas em serviços de urgência e emergência. Métodos: Estudo de intervenção conduzido em uma Unidade de Pronto Atendimento. Os pacientes admitidos na pesquisa receberam acompanhamento farmacoterapêutico por meio de avaliação e intervenção na farmacoterapia. Resultados: Participaram do estudo 197 pacientes majoritariamente feminino, comórbidos, com média de idade de 43 anos ± 13. Foram realizadas intervenções em 130 destes, com aceitação de 83% por parte da equipe de assistência. As intervenções também repercutiram na farmacoeconomia, proporcionando uma redução de custos de 35% em comparação ao semestre anterior. Conclusão: Nossos resultados expressaram que a presença do farmacêutico clínico é essencial para farmacoterapias otimizadas e redução de custos hospitalares.

Objective: To clarify pharmaceutical interventions' pharmacotherapeutic and pharmacoeconomic impact on urgent and emergency services. Methods: Intervention study conducted in an Emergency Care Unit. Patients enrolled in the research received pharmacotherapeutic follow-up through evaluation and intervention in pharmacotherapy. Results: One hundred and ninety seven patients, mostly female, with comorbid conditions, with a mean age of 43 years ± 13, participated in the study. Interventions were performed in 130 of them, with an acceptance of 83% by the care team. The interventions also impacted pharmacoeconomics, providing a cost reduction of 35% compared to the previous semester. Conclusion: Our results expressed that the presence of the clinical pharmacist is essential for optimized pharmacotherapies and hospital cost reduction.

Pharmaceutical Services , Health Education , Economics, Pharmaceutical , Drug Therapy , Emergency Medical Services
Rev. Ciênc. Plur ; 8(3): 28241, out. 2022. tab
Article in Portuguese | LILACS, BBO | ID: biblio-1399069


Introdução:A legislação do Sistema Único de Saúde confere aos Conselhos de Saúde, enquanto órgãos colegiados deliberativos, a competência para fiscalizar as ações de saúde e deliberar sobre as temáticas de interesse da gestão em saúde e do controle social.Objetivo:Analisar a atuação do Conselho Nacional de Saúde no enfrentamento à pandemia de COVID-19.Metodologia:Trata-se de uma análise documental, de natureza descritiva e com abordagem qualitativa, realizada entre outubro e novembro de 2021. Os atos normativos foram recuperados do sitedo Conselho Nacional de Saúde e analisados à luz do referencial teórico-metodológico da Análise de Conteúdo.Resultados:Entre 86 atos normativos expedidos pelo Conselho Nacional de Saúde, 20 foram incluídos no estudo por apresentarem relação direta com as medidas de enfrentamento à emergência de saúde pública de importância internacional provocada pelo vírus SARS-COV-2. A partir do teor e das aproximações temáticas dos documentos selecionados, eles foram organizados em três categorias: Atenção à Saúde; Gestão Orçamentária e Financeira; e Saúde e Segurança nos Serviços de Saúde.Conclusões:Apesar da não observância da edição de resoluções, instrumento com maior poder de vinculação ao ato do gestor da saúde, restringindo-se a emissão de recomendações, o Conselho Nacional de Saúde desenvolveu seu papel institucional e político, necessário na atual conjuntura, principalmente num cenário que ao longo dos últimos anos vem mitigando a legitimidade dos espaços de controle e participação social no Brasil (AU).

Introduction:The legislation of the Unified Health System grants the Health Councils, as deliberative collegiate bodies, the competence to supervise health actions and deliberate on topics of interest to health management and social control.Objective:To analyze the performance of the National Health Council in coping with the COVID-19 pandemic.Methodology:This is a documentary analysis, with a descriptive nature and a qualitative approach, carried out between October and November 2021. The normative acts were retrieved from the website of the National Health Council and analyzed in the light of the theoretical-methodological framework of Content Analysis.Results:Among 86 normative acts issued by the National Health Council, 20 were included in the study because they were directly related to measures to cope with the public health emergency of international importance caused by the SARS-COV-2 virus. Based on the content and thematic approaches of the selected documents, they were organized into three categories: Health Care; Budget and Financial Management; and Health and Safety in Health Services.Conclusions:Despite the non-compliance with the issue of resolutions, an instrument with greater power of linking to the act of the health manager, restricting the issuing of recommendations, the National Health Council has developed its institutional andpolitical role, necessary in the current situation, mainly in a scenario that over the last few years has been mitigating the legitimacy of spaces for social control and participation in Brazil (AU).

Introducción: La legislación del Sistema Único de Salud otorga a los Consejos de Salud, como órganos colegiados deliberativos, la competencia para inspeccionar las acciones de salud y deliberar sobre los temas de interés de la gestión en salud y el control social. Objetivo: Analizar el desempeño del Consejo Nacional de Salud en el enfrentamiento de la pandemia de COVID-19. Metodología: Se trata de un análisis documental, de carácter descriptivo y con enfoque cualitativo, efectuado entre octubre y noviembre de 2021. Los actos normativos fueron recuperados del sitio web del Consejo Nacional de Salud y analizados a la luz del marco teórico-metodológico del Análisis de Contenido. Resultados: De los 86 actos normativos emitidos por elConsejo Nacional de Salud, 20 fueron incluidos en el estudio porque estaban directamente relacionados con las medidas para enfrentar la emergencia de salud pública de relevancia internacional provocada por el virus SARS-COV-2. Con base en el contenido y las aproximaciones temáticas de los documentos seleccionados, estos fueron organizados en tres categorías: Atención a la Salud; Gestión Presupuestaria y Financiera; y Salud y Seguridad en los Servicios de Salud.Conclusiones: A pesar del incumplimiento en relación con la edición de las resoluciones, un instrumento con mayor poder para vincular el acto del gestor de la salud, limitándose a emitir recomendaciones, el Consejo Nacional de Salud ha desarrollado su rol institucional y político, necesario en la situación actual, especialmente en un escenario que en los últimos años ha mitigado la legitimidad de los espacios de control y participación social en Brasil (AU).

Humans , Social Control, Formal , Enacted Statutes , Health Councils/organization & administration , COVID-19/prevention & control , Pharmaceutical Services/standards , Brazil , Occupational Health/standards , Health Management , Delivery of Health Care , Qualitative Research , Healthcare Financing
Article in Portuguese | ECOS, LILACS | ID: biblio-1412810


Objetivo: Avaliar o custo com medicamentos básicos de uso contínuo de usuários da Atenção Primária em Saúde de Santa Rosa-RS. Métodos: Estudo transversal e analítico realizado em um município do noroeste do Rio Grande do Sul. Foram incluídos usuários cadastrados nas 17 unidades de estratégia de saúde da família, das áreas urbana e rural, em uso de no mínimo um medicamento de uso contínuo. A coleta de dados foi realizada pelo acesso ao sistema informatizado de prescrição eletrônica. Resultados: Foram incluídos 642 usuários, com idade média de 60,40 anos, sendo 64,3% mulheres. Identificou-se média de 4,68 ± 2,82 medicamentos/prescrição e 47,4% ± 14,48 dos usuários em uso de cinco ou mais medicamentos. Dos medicamentos em uso, 87,9% pertencem ao componente básico da assistência farmacêutica. O custo anual do município por usuário de medicamento foi em média de R$ 250,60. O sistema cardiovascular foi o grupo anatômico com maior custo total. Verificou-se maior frequência de uso de medicamentos entre os idosos, que consequentemente representam o grupo etário com maior custo de tratamento. Conclusão: Evidenciou-se que a maioria dos medicamentos prescritos atua sobre os sistemas cardiovascular e nervoso, e pertence ao componente básico da assistência farmacêutica. O custo com medicamentos demonstrou investimento do município de valores 25 vezes maiores do que o mínimo estabelecido pela legislação vigente, com vistas a garantia de acesso ao tratamento e manutenção da qualidade de vida da população assistida.

Objective: The objective of this study was to evaluate the cost of basic medicines for continuous use by users of Primary Health Care in Santa Rosa-RS. Methods: A cross-sectional and analytical study carried out in primary health care in a city in the Northwest of Rio Grande do Sul, comprising 17 unites of Strategies Family Health. Registered users in urban and rural units were included, using at least one continuous treatment. Data collection was performed by accessing the computerized electronic system. Results: 642 users were included in the study, with an average age of 60.40 ± 14.48 years, 64.3% were women. The average number of prescription drugs was 4.68 ± 2.82/prescription and 47.4% of users were using five or more medications. Of the drugs in use, 87.9% belonging to the basic component of pharmaceutical care. These drugs represent an annual cost per user of R$ 250.60. The cardiovascular system presents itself as the anatomical group with the highest total expenditure. Hydrochlorothiazide was the most prescribed drug and beclomethasone represented the highest individual expense. Conclusion: It became evident that most of the drugs prescribed belonged to the basic component of pharmaceutical care and belonged to the cardiovascular and nervous system. Cost of drug implies the investment of the city of 25 times higher than the established by the current legislation, with a view to guaranteeing access to treatment and maintaining the quality of life of the assisted population.

Pharmaceutical Services , Primary Health Care , Health Expenditures , Drug Utilization
Int. j. cardiovasc. sci. (Impr.) ; 35(3): 318-326, May-June 2022. tab, graf
Article in English | LILACS | ID: biblio-1375642


Abstract Background: Uncontrolled blood pressure has been associated with poor adherence to drug treatment. Objectives: To assess blood pressure control in hypertensive patients attending primary health centers after implementation of a pharmaceutical follow-up program in a city of the north of Brazil. Methods: Observational, cross sectional, descriptive study with 163 hypertensive patients attending public primary health care centers - one located on the riverside and one in the urban area of the city of Santarem, western Pará, Brazil. Adherence to the anti-hypertensive treatment was assessed using the eight-item Morisky test. Pharmacotherapy follow-up (Dader method) of patients with uncontrolled hypertension and non-adherent to anti-hypertensive treatment was performed. Results of the normality test showed that the data did not follow a normal distribution. Continuous variables were then compared using the Wilcoxon signed-rank test, and categorical variables by the likelihood ratio and the McNemar tests. Statistical significance was set at 5%. Results: Of the total sample, 94.5% were not adherent to anti-hypertensive drug therapy and 77.2% had uncontrolled hypertension. Adherence rate was higher in men than women (p=0.006). Pharmacotherapy follow-up improved blood pressure levels, particularly systolic blood pressure (p<0.001). Conclusion: An individualized pharmacotherapeutic follow-up, considering regional and cultural specificities, can contribute to the treatment of hypertensin in the primary care.

Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Pharmacists , Pharmaceutical Services , Primary Health Care/methods , Medication Adherence , Hypertension/drug therapy , Personal Health Services/methods , Brazil , Health Centers , Urban Health , Drug Therapy/methods , Hypertension/prevention & control
Int. j. cardiovasc. sci. (Impr.) ; 35(3): 342-353, May-June 2022. tab
Article in English | LILACS | ID: biblio-1375653


Abstract Background: Public programs that provide access to essential medications have played an important role in the care of hypertensive and diabetic patients. However, access in small municipalities has been poorly studied. Objectives: To describe the sociodemographic profile and the medication and health service usage of patients with systemic arterial hypertension and/or diabetes mellitus in a small municipality who use the public medication access programs Health has no Price (Saúde Não Tem Preço - SNTP) and the Minas Pharmacy Network. Methods: This cross-sectional study with 341 participants was conducted in 2019. Home interviews were conducted using a standardized, semi-structured questionnaire. The data are expressed as absolute and relative frequencies, and Pearson's chi-square test was used for comparisons between proportions (α = 5%). Results: Most of the participants (70.68%) had hypertension only, 11.14% had diabetes only, and 18.18% had both. Regarding the origin of the hypertension medications, 82.67% were provided by the Minas Pharmacy Network and/or SNTP programs. Regarding oral hypoglycemic agents and insulins, 88.61% were provided by the Minas Pharmacy Network and/or SNTP. Most participants were female (63.1%), at least 65 years of age (50.30%), non-White (66.96%), resided in an urban area (67.16%), were illiterate or had a low education level (89.94%), and had a maximum income ≤ 2 times the federal minimum salary (89.19%). Overall user perception was significantly better for SNTP (p=0.010). Conclusion: The results of this study indicate that programs which provide access to essential medications are important sources of hypertension and diabetes medications in the study area, especially for people with low incomes.

Diabetes Mellitus/epidemiology , National Drug Policy , Access to Essential Medicines and Health Technologies , Hypertension/epidemiology , Pharmaceutical Services/supply & distribution , Cross-Sectional Studies , Diabetes Mellitus/drug therapy , Hypertension/drug therapy
Rev. Ciênc. Méd. Biol. (Impr.) ; 21(1): 60-66, maio 05,2022. fig
Article in Portuguese | LILACS | ID: biblio-1370675


Introdução: a hanseníase é uma doença de fácil diagnóstico, possuindo tratamento e cura. Quando diagnosticada tardiamente, pode trazer graves consequências para os portadores e seus familiares. Uma vez que o tratamento da hanseníase está inserido no componente estratégico da assistência farmacêutica, são exigidos cuidados e orientação. Há necessidade de intervenção clínica farmacêutica, com objetivo de acompanhar prescrições medicamentosas, analisando a adesão dos pacientes ao tratamento com a promoção de ações de educação em saúde, além de minimizar a ocorrência de eventos adversos relacionados aos fármacos do tratamento com possível redução de custos associados aos agravos. Objetivo: realizar o monitoramento para identificar e tratar as possíveis intercorrências que estão comumente presentes no tratamento de hanseníase. Metodologia: a realização do estudo deu-se com o acompanhamento dos pacientes atendidos no serviço de referência a partir da aplicação de questionários em consultas periódic as, vis to que a adesão ao tratamento, reduç ão dos eventos adver sos e controle dos comunic antes são de suma impor tância para o controle epidemiológico. Resultados: os principais sintomas dos indivíduos acometidos foram dormência e eritema nodoso hansênico. A maioria utilizava como tratamento o esquema multibacilar e talidomida. O acometimento relatado dos pacientes foi em nível moderado. Os pacientes possuíam comorbidades como hipertensão, artrose e diabetes. O acompanhamento clínico foi relatado como positivo pela maioria dos entrevistados. Conclusão: o desfecho do estudo mostra que a adesão do paciente é crucial para o êxito do tratamento e o acompanhamento do farmacêutico clínico constitui um pilar positivo, contribuindo para a prevenção de agravos e conscientização da comunidade.

Introduction: Hansen's disease is an easily diagnosed disease, with treatment and cure available. When diagnosed late, it can bring serious consequences for patients and their families. Since the treatment of Hansen's disease is part of the strategic component of pharmaceutical assistance, care and guidance are required. There is a need for clinical pharmaceutical intervention, aiming to monitor drug prescriptions, analyze patients' adherence to treatment while promoting health education actions, in addition to minimizing the occurrence of adverse events related to treatment drugs with possible reduction in costs associated to grievances. Objective:thus, the present study aimed to monitor, identify, and treat possible complications commonly present in the treatment of Hansen's disease. Methodology: The study was carried out with the follow-up of patients seen at the reference service, through the application of questionnaires in periodic appointments, since adherence to treatment, reduction of adverse events and control of communicants are of short importance for epidemiological control. Results:The main symptoms of Hansen's disease patients were numbness and leprosy nodosum erythema. Most used the multibacillary scheme and thalidomide as treatment. The reported involvement of patients was at a moderate level. Patients had other comorbidities such as hypertension, arthrosis and diabetes. The clinical assistance was reported as positive by most interviewees. Conclusion: The outcome of the study shows that patient's compliance is crucial for the success of treatment and the clinical pharmacist's accompaniment is a positive pillar, contributing to the prevention of complications and community awareness.

Humans , Male , Female , Pharmaceutical Services , Thalidomide/therapeutic use , Leprosy/drug therapy , Health Centers , Cross-Sectional Studies
Article in Portuguese | LILACS, ECOS | ID: biblio-1412124


Objetivo: Sintetizar os principais pontos abordados em investigações de Disposição a Pagar (DAP) por serviços farmacêuticos, com foco no Método de Valoração Contingente (MVC). Métodos: Foi realizada uma revisão não sistemática com recuperação e análise de manuscritos publicados até novembro de 2020. A busca por estudos ocorreu nas bases MEDLINE, LILACS e SciELO. Resultados: Foram discutidos os fundamentos teóricos e processos metodológicos da análise, apresentando o MVC como principal perspectiva de abordagem. Enquanto delineamento do questionário, é sugerida uma estrutura que apresente, sequencialmente, os elementos: "conhecimento do participante sobre a intervenção", "apresentação da intervenção", "cenário hipotético", "pergunta DAP", "estado de saúde percebido" e "informações socioeconômicas". No mais, é enfatizada a importância da execução de etapas de validação, tanto do instrumento quanto da avaliação. Conclusão: Avaliar a preferência declarada da população por serviços farmacêuticos é uma estratégia ainda limitada. Se realizado adequadamente, esse tipo de investigação pode auxiliar gestores e tomadores de decisão no processo de implementação de novas tecnologias de cuidado.

Objective: To synthesize key points addressed in investigations of Willingness to Pay (WTP) for pharmaceutical care services, focusing on the Contingent Valuation Method (CVM). Methods: We performed a non-systematic review with recovery and analysis of manuscript published until November 2020. Three databases were majorly searched, including MEDLINE, LILACS and SciELO. Results: The theoretical foundations and methodological process were discussed, presenting the CVM as the main perspective. For questionnaire design, is suggested a structure that sequentially presents the elements: "participant knowledge on intervention", "intervention presentation", "hypothetical scenario", "WTP question", "perceived health status", and "socioeconomic information". In addition, we emphasize the importance of executing validation steps for the instrument of measurement as well as the evaluation process. Conclusion: Assessing the population's declared preference for pharmaceutical services is still a limited strategy. If carried out properly, this type of investigation can help managers and decision makers in the process of implementing technologies of care.

Pharmaceutical Services , Cost-Benefit Analysis , Economics, Pharmaceutical , Costs and Cost Analysis
Rev. bras. med. fam. comunidade ; 17(44): 2432, 20220304. tab
Article in Portuguese | LILACS, ColecionaSUS | ID: biblio-1380388


Introdução: A não conformidade de prescrições de medicamentos com normativas que regulamentam esse processo é uma realidade do processo de cuidado em saúde. Objetivo: Este estudo teve como objetivo analisar prescrições médicas e odontológicas do sistema primário de saúde do município de Angicos, Rio Grande do Norte de acordo com a legislação em vigor. Métodos: Desenvolveu-se estudo transversal de caráter descritivo-exploratório. Constituíram objeto de análise segundas vias de prescrições e receituário de controle especial elaborados por todos os médicos e odontólogos lotados na atenção primária desse município, no período de janeiro a junho de 2018. Verificaram-se itens como presença de nome do paciente, idade, sexo, via de administração, dosagem/concentração, duração do tratamento, nomenclatura do medicamento, carimbo e assinatura do prescritor. Resultados: Analisaram-se 3.725 prescrições, em que 566 (15,19%) estavam não conformes com a legislação, sendo mais problemáticos os itens identificação do usuário (68,02%), data da prescrição (34,10%), nomenclatura do medicamento por denominação comum brasileira/internacional (18,02%), duração do tratamento (13,96%) e posologia (10,60%). Conclusões: Esses resultados apontam para a necessidade de que estratégias de educação permanente e fiscalização quanto ao cumprimento da legislação sejam desenvolvidas de forma mais assídua.

Introduction: The non-compliance of drug prescriptions with regulations that control this process is a reality of the health care process. Objectives: Thus, this study aimed to analyze medical and dental prescriptions of the primary health system in the city of Angicos-Rio Grande do Norte, in accordance with the current law. Methods: Accordingly, a cross-sectional descriptive-exploratory study was conducted. Second copies of prescriptions and special control prescriptions prepared by all physicians and dentists working in primary health care in this municipality, from January to June 2018, were analyzed. Information included the patient's name, age and sex. route of administration, dosage/concentration, duration of treatment, drug nomenclature, and stamp and signature of the prescriber. Results: A total of 3,725 prescriptions were analyzed, in which 566 (15.19%) were not in compliance with the law, where most problematic were user identification (68.02%), date of prescription (34.1%). drug nomenclature (DCB/DCI) (18.02%), duration of treatment (13.96%) and dosage (10.6%). Conclusions: These results point to the need for permanent education and inspection strategies regarding compliance with the law to be developed more assiduously.

Introducción: El incumplimiento de la prescripción de medicamentos con la normativa que regula este proceso es una realidad del proceso asistencial. Objetivo: Así, este estudio tuvo como objetivo analizar las prescripciones médicas y odontológicas del sistema primario de salud de la ciudad de Angicos-RN, de acuerdo con la legislación vigente. Métodos: Por tanto, se desarrolló un estudio descriptivo-exploratorio transversal. Se analizaron segundas copias de prescripciones y prescripciones especiales de control elaboradas por todos los médicos y odontólogos que laboran en la atención primaria de este municipio, de enero a junio de 2018. Se verificaron ítems como la presencia del nombre del paciente, edad, sexo, administración, dosis/concentración, duración del tratamiento, nomenclatura del fármaco, sello y firma del prescriptor. Resultados: Se analizaron un total de 3.725 prescripciones, de las cuales 566 (15,19%) no cumplieron con la legislación, siendo más problemáticos los ítems identificación de usuario (68,02%), fecha de prescripción (34,1%), nomenclatura de medicamentos. DCB / DCI (18,02%), duración del tratamiento (13,96%) y posología (10,6%). Conclusiones: Estos resultados apuntan a la necesidad de que se desarrollen con mayor asiduidad estrategias de educación continua y de inspección sobre el cumplimiento de la legislación.

Pharmaceutical Services , Drug Prescriptions , Primary Health Care
Ciênc. Saúde Colet. (Impr.) ; 27(3): 1191-1203, mar. 2022. tab
Article in Portuguese | LILACS | ID: biblio-1364689


Resumo Estudo transversal da disponibilidade de medicamentos prescritos na Atenção Primária, com amostra probabilística de 1221 usuários das farmácias públicas de município polo de saúde em Minas Gerais, em 2017. Foram estimados indicadores de disponibilidade dos medicamentos e realizou-se regressão logística hierárquica, segundo o modelo comportamental de uso de serviços de saúde. Apenas 39,3% dos usuários receberam todos os medicamentos nas quantidades prescritas. Os medicamentos mais e menos disponíveis foram, respectivamente, os que atuam no sistema digestivo/metabolismo, e no sangue e órgãos hematopoiéticos. A disponibilidade integral do tratamento se mostrou associada a mais escolaridade (≥ 8 anos OR: 1,7; IC 95%: 1,3-2,4); proximidade até a farmácia (≤15 min OR: 1,7; IC 95%: 1,2-2,3); ausência de gastos privados com medicamentos (OR: 2,2; IC 95%: 1,7-2,9) e menor número de medicamentos prescritos (≤ 2 OR: 3,2; IC 95%: 2,3-4,4; 3/4 OR: 1,6; IC 95%: 1,2-2,1). Esses resultados mostram diferenças na disponibilidade de medicamentos dentro do SUS, evidenciando a necessidade de reorganização da rede de atendimento dos serviços de dispensação e do planejamento das aquisições de medicamentos, além da proposição de políticas públicas que priorizem a população mais vulnerável.

Abstract This is a cross-sectional study on the availability of prescribed medicines in Primary Health Care (PHC), with a probabilistic sample of 1,221 users of public pharmacies in a health pole municipality in Minas Gerais, in 2017. Medicine availability indicators were estimated, and a hierarchical logistic regression was performed, according to the behavioral model of health service use. Only 39.3% of patients received all medicines in the prescribed quantities. The most and the least available medicines were, respectively, those for the digestive system/metabolism, and for blood and hematopoietic organs. Full availability of the prescribed treatment was associated with higher schooling (≥ 8 years OR: 1.7; 95% CI: 1.3-2.4); proximity to the pharmacy (≤15 min OR: 1.7; 95% CI: 1.2-2.3); absence of out-of-pocket expenditure on medicines (OR: 2.2; 95% CI: 1.7-2.9), and a smaller number of prescription drugs (≤ 2 OR: 3.2; 95% CI: 2.3-4.4; 3/4 OR: 1.6; 95% CI: 1.2-2.1). These results showed differences in medicine availability within the Brazilian Unified Health System (SUS), and highlighted the need to reorganize the dispensing services network and pharmaceutical procurement planning, as well as to develop public policies to protect the vulnerable population.

Humans , Pharmacies , Pharmaceutical Services , Prescription Drugs , Primary Health Care , Cross-Sectional Studies
Porto Alegre; Editora Rede Unida; 20220112. 170 p.
Monography in Portuguese | LILACS | ID: biblio-1361950


Diante desse contexto, sindêmico no Brasil e no mundo, o livro "Ciência, Tecnologia, Vigilância em Saúde e Assistência Farmacêutica, políticas públicas oriundas do controle social, garantidoras de democracia, soberania nacional e acesso à saúde" pretende abordar e comprovar o quão estas políticas públicas são fundamentais para salvar vidas e contribuir para o desenvolvimento sustentável do país. Esta coletânea irá transcorrer, apresentando experiências, a importância da efetivação das políticas públicas de saúde, as ações necessárias para imunização contra a COVID-19 e ecoando a atuação do controle social do SUS, através das proposições das Comissões Intersetoriais de Ciência, Tecnologia, Assistência Farmacêutica e Vigilância em Saúde, assessoras do Conselho Nacional de Saúde.

Pharmaceutical Services , Social Control, Formal , Public Health Surveillance
Braz. J. Pharm. Sci. (Online) ; 58: e19613, 2022. tab
Article in English | LILACS | ID: biblio-1383958


Abstract Highly Active Antiretroviral therapy (HAART) depends on optimal adherence to be effective. Pharmacotherapeutic follow-up can be used as a strategy for treatment fidelity. To provide pharmaceutical care for HAART patients, to assess adherence, to identify and resolve drug related problems (DRP). This is a prospective, interventional study aimed at people on HAART. Data was collected using the pharmacotherapeutic follow-up form and CEAT-VIH. There was a predominance of women (59%), older than 33 years (75%), mostly single (43%). Regarding adherence, 64% had insufficient adherence at the start of the study, while 36% had strict/adequate adherence. After the pharmacotherapeutic follow-up, 70% presented strict/adequate adherence. Regarding HAART, the relationship between adhesion versus time of HAART and adherence versus regimen used was significant, considering that less time of therapy and regimen containing protease inhibitors are predictors for insufficient adherence. Regarding the DRP identified (f=77), missed pills (32%), untreated disease, incorrect management frequency, and undue self-medication (12%) were the most frequent. Pharmaceutical interventions (f=137) were predominantly advising related to specific pharmacological treatment (32%), non-pharmacological measures (20%), and medication suspension (9%). Pharmaceutical care was shown to be animportant strategy, within the multi professional team, to improve adherence, besides identifying and resolving DRP.

Humans , Male , Female , Adult , Pharmaceutical Services/classification , Acquired Immunodeficiency Syndrome/pathology , HIV/pathogenicity , Antiretroviral Therapy, Highly Active/instrumentation , Treatment Adherence and Compliance , Pharmaceutical Preparations/administration & dosage
Braz. J. Pharm. Sci. (Online) ; 58: e19929, 2022. tab, graf
Article in English | LILACS | ID: biblio-1383967


Abstract The objectives of this study were to describe work characteristics of Iraqi pharmacists, to compare pharmacist job satisfaction between private and public sectors and to assess factors influencing job satisfaction level. This cross-sectional study of pharmacists, their work sites and work satisfactions used an electronic questionnaire that was posted on Facebook pharmacy professional group from June to September 2018. The participants included pharmacists from all 18 Iraqi provinces. We used multiple linear regression to identify predictors of general job satisfaction among 13 pharmacist characteristics. We received 658 usable surveys. Approximately half (47.24%) of respondents indicated dissatisfaction with their primary workplace. Job performance, patient contact, satisfaction with manager, income and expectation satisfactions were significantly related with work satisfaction. Pharmacists working in the private sector had significantly more control over their workplace and higher satisfaction with manager, income and general satisfactions compared to those working in public sector. Pharmacists work in diverse settings across the public healthcare system, community pharmacies, private drug bureaus and academia. About half of them are dissatisfied with their primary workplace. The private sector has more satisfaction rate compared to the public sector. Thus, officials need to improve job environments in the public sector.

Pharmacists/ethics , Pharmacy/classification , Pharmaceutical Services/organization & administration , Iraq/ethnology , Job Satisfaction , Cross-Sectional Studies/methods , Surveys and Questionnaires/statistics & numerical data , Workload/statistics & numerical data , Workplace/classification , Public Sector , Private Sector , Delivery of Health Care , Work Performance/statistics & numerical data , Motivation/ethics
Braz. J. Pharm. Sci. (Online) ; 58: e19500, 2022. tab, graf
Article in English | LILACS | ID: biblio-1383990


Abstract The pursuit of quality of life, which has become marked in recent years, has translated into important population health benefits. This study assessed the quality of life of patients with type 2 diabetes (T2DM) who received pharmaceutical care, and their satisfaction with the service provided in community pharmacies. This single blind, randomized controlled clinical trial included 100 patients. The intervention group (N=47) received pharmaceutical care by a clinical pharmacist and the control group (N=42) received standard care. The Quality of Life Diabetes Questionnaire (DQOL) was used to measure all participants´ quality of life at study enrollment and six months later. Satisfaction of the participants in the intervention group was measured using a validated 14-items questionnaire. At the end of the study, participants in the intervention group had a statistically significant improvement in DQOL scores ( -0.62 x 1.57, p < 0.001) and were highly satisfied with the intervention (96% excellent satisfaction scores). Pharmaceutical care practice was associated with high satisfaction and increased quality of life scores in T2DM patients. These results underscore the important role of pharmacists to improve the health of diabetic patients.

Humans , Male , Female , Adult , Patients/classification , Quality of Life , Randomized Controlled Trial , Practice Patterns, Pharmacists'/ethics , Pharmaceutical Services , Patient Satisfaction , Diabetes Mellitus, Type 2/pathology